Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?


OverviewForecastFinancialsChart

Bicara Therapeutics Ownership Summary


Bicara Therapeutics is owned by 93.81% institutional investors, 12.23% insiders. Ra capital management is the largest institutional shareholder, holding 12.75% of BCAX shares.

BCAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBicara Therapeutics93.81%12.23%-6.05%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.96M12.75%$109.84M
Siren5.22M9.57%$82.38M
Vestal point capital, lp5.10M9.35%$80.53M
Red tree management3.17M5.81%$50.06M
Tpg gp a3.01M5.52%$47.53M
Fmr2.70M4.95%$42.61M
Deep track capital, lp2.43M4.45%$38.32M
Blackrock funding, inc. /de2.31M4.24%$36.50M
Omega fund management2.20M4.04%$34.81M
Vanguard group2.20M4.04%$34.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Red tree management3.17M60.39%$50.06M
Omega fund management2.20M15.66%$34.81M
Acorn capital advisors643.38K5.16%$10.16M
Vestal point capital, lp5.10M3.64%$80.53M
Siren5.22M3.22%$82.38M
Superstring capital management lp175.90K2.74%$2.78M
Sectoral asset management266.50K2.60%$4.21M
Tpg gp a3.01M2.59%$47.53M
Aisling capital management lp568.92K1.97%$8.98M
Ra capital management6.96M1.35%$109.84M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management464.73K0.00%464.73K
Clearbridge investments324.32K0.00%324.32K
Silverarc capital management250.61K0.53%250.61K
Schonfeld strategic advisors504.08K0.05%241.33K
Blackrock funding, inc. /de2.31M0.00%200.47K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---2.16M
Deerfield management company, l.p. (series c)---1.80M
Wellington management group llp---1.39M
Janus henderson group---1.34M
Adage capital partners gp---1.18M

New Positions

HolderShares% AssetsChangeValue
T. rowe price investment management464.73K0.00%464.73K$7.34M
Clearbridge investments324.32K0.00%324.32K$5.12M
Silverarc capital management250.61K0.53%250.61K$3.96M
Cantor fitzgerald, l. p.100.00K0.01%100.00K$1.58M
Exoduspoint capital management, lp53.88K0.01%53.88K$850.80K

Sold Out

HolderChange
Mrp capital investments-20.00
Rothschild investment-20.00
Signaturefd-80.00
Kessler investment group-200.00
Spire wealth management-1.80K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202510519.32%51,165,42915.59%931.42%7946.30%16-
Mar 31, 20259213.58%48,567,5534.69%891.23%54-10.00%18157.14%
Dec 31, 20248322.06%46,705,50728.51%851.92%62-8.82%7-
Sep 30, 202468-36,343,123-66-68---

Recent Insider Transactions


DateNameRoleActivityValue
Oct 15, 2025Cohlhepp Ryan President and COOSell$145.24K
Oct 15, 2025Cohlhepp Ryan President and COOSell$81.70K
Oct 13, 2025Mazumdar Claire Chief Executive OfficerSell$216.55K
Oct 15, 2025Mazumdar Claire Chief Executive OfficerSell$250.39K
Oct 09, 2025Raben David Chief Medical OfficerSell$405.90K

Insider Transactions Trends


DateBuySell
2025 Q4-13
2025 Q3-2
2025 Q2-1
2025 Q1-2
2024 Q33-

BCAX Ownership FAQ


Who Owns Bicara Therapeutics?

Bicara Therapeutics shareholders are primarily institutional investors at 93.81%, followed by 12.23% insiders and -6.04% retail investors. The average institutional ownership in Bicara Therapeutics's industry, Biotech Stocks , is 295.31%, which Bicara Therapeutics falls below.

Who owns the most shares of Bicara Therapeutics?

Bicara Therapeutics’s largest shareholders are Ra capital management (6.96M shares, 12.75%), Siren (5.22M shares, 9.57%), and Vestal point capital, lp (5.1M shares, 9.35%). Together, they hold 31.67% of Bicara Therapeutics’s total shares outstanding.

Does Blackrock own Bicara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicara Therapeutics.

Who is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested?

Red tree management is Bicara Therapeutics’s biggest shareholder by percentage of total assets invested, with 60.39% of its assets in 3.17M Bicara Therapeutics shares, valued at 50.06M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools